SEC Filing Summary: Sunshine Heart, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Sunshine Heart, Inc. on June 25, 2015, reporting events occurring on June 19, 2015. The filing addresses Item 5.02 regarding the departure of a senior officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data disclosed relates to a specific severance agreement:
- Severance Payment: $350,000 (one-time lump sum).
- COBRA Coverage: $5,936.40.
- Total Compensation Cost: $355,936.40.
Material Changes
The material change reported is the separation of Kimberly A. Oleson, Senior Vice President of Clinical Affairs, effective June 19, 2015. This departure was formalized through a separation and release agreement.
Management Commentary and Risks
Ms. Oleson agreed to a full release of claims against the Company. The filing does not contain forward-looking guidance, general risk factors, or commentary on the company's future outlook beyond the terms of this specific separation.
Investor Verification Checklist
- Verify the impact of the Senior Vice President of Clinical Affairs' departure on ongoing clinical trials and product development.
- Confirm the accounting treatment of the $355,936.40 severance cost in the upcoming quarterly report.
- Review subsequent filings for the appointment of a replacement for the vacant executive role.